SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000882104-19-000040
Filing Date
2019-04-16
Accepted
2019-04-16 17:17:19
Documents
1
Period of Report
2019-03-28

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_155544942380841.html 4/A  
1 FORM 4/A wf-form4a_155544942380841.xml 4/A 4732
  Complete submission text file 0000882104-19-000040.txt   6195
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451
Business Address
Stone Christopher Lewis (Reporting) CIK: 0001453373 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-19756 | Film No.: 19751663